The Effectiveness of Lapatinib in HER2-Positive Metastatic Breast Cancer Patients Pretreated With Multiline Anti-HER2 Treatment: A Retrospective Study in China

BACKGROUND: The aim of this study was to evaluate the effectiveness of lapatinib in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer. METHODS: We retrospectively reviewed the medical records of patients who received lapatinib for salvage treatment at any line setting...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xinzhao, Wang, Lin, Yu, Qian, Liu, Zhaoyun, Li, Chao, Wang, Fukai, Yu, Zhiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351035/
https://www.ncbi.nlm.nih.gov/pubmed/34342244
http://dx.doi.org/10.1177/15330338211037812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351035/
https://www.ncbi.nlm.nih.gov/pubmed/34342244
http://dx.doi.org/10.1177/15330338211037812

Ejemplares similares